Recursion Pharmaceuticals Raises $200 Million Through Share Offering
PUBLIC · RXRXOct 15, 2026
Amount Raised
$200 Million
Round Type
Post-IPO Equity
Salt Lake CityBiotechnologyHealthcareHealth CareArtificial IntelligenceTherapeuticsPharmaceutical
Investors
Evercore Group L.L.C.Morgan Stanley & Co. LLCGoldman Sachs & Co. LLCLeerink Partners LLC
Description
On October 15, 2026, Recursion Pharmaceuticals entered into an underwriting agreement to sell 61,540,000 shares of its Class A common stock at a price of $3.25 per share. The gross proceeds from this offering are expected to be approximately $200 million, before deductions. The offering is slated to close on October 16, 2026, pending customary closing conditions. This capital infusion will support Recursion's ongoing drug discovery efforts.
Who to call at Recursion Pharmaceuticals, and when
A new round usually means Recursion Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Recursion Pharmaceuticals raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Recursion Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Recursion Pharmaceuticals. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Recursion Pharmaceuticals
Location
41S Rio Grande Street
Salt Lake City, Utah, United States
About
Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technology to discover and develop potential new drugs. The company focuses on therapeutics in disease areas with significant unmet medical need. Through its innovative platform, Recursion aims to transform the process of drug discovery. With a commitment to improving patient outcomes, the company is at the forefront of using data-driven approaches in medicine.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Recursion Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.